Alkeon Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-500,000
| Closed | -$70.1M | – | 99 |
|
|
2017
Q3 | $70.1M | Buy |
+500,000
| New | +$70.1M | 0.5% | 36 |
|
|
2017
Q1 | – | Sell |
-404,202
| Closed | -$49.5M | – | 69 |
|
|
2016
Q4 | $49.5M | Sell |
404,202
-26,043
| -6% | -$3.19M | 0.98% | 43 |
|
|
2016
Q3 | $52.7M | Sell |
430,245
-650
| -0.2% | -$79.7K | 0.99% | 37 |
|
|
2016
Q2 | $53.6M | Buy |
430,895
+355
| +0.1% | +$44.2K | 1.03% | 38 |
|
|
2016
Q1 | $59.9M | Buy |
430,540
+670
| +0.2% | +$93.3K | 1.24% | 33 |
|
|
2015
Q4 | $82M | Sell |
429,870
-257,000
| -37% | -$49M | 1.66% | 26 |
|
|
2015
Q3 | $113M | Hold |
686,870
| – | – | 2.36% | 17 |
|
|
2015
Q2 | $124M | Hold |
686,870
| – | – | 2.42% | 15 |
|
|
2015
Q1 | $119M | Sell |
686,870
-43,700
| -6% | -$7.57M | 2.27% | 20 |
|
|
2014
Q4 | $135M | Sell |
730,570
-248,000
| -25% | -$45.9M | 2.64% | 15 |
|
|
2014
Q3 | $162M | Hold |
978,570
| – | – | 3.22% | 7 |
|
|
2014
Q2 | $153M | Buy |
978,570
+43,940
| +5% | +$6.87M | 2.79% | 8 |
|
|
2014
Q1 | $142M | Buy |
934,630
+70,000
| +8% | +$10.6M | 2.4% | 14 |
|
|
2013
Q4 | $115M | Buy |
864,630
+133,000
| +18% | +$17.7M | 1.94% | 25 |
|
|
2013
Q3 | $85M | Buy |
731,630
+106,630
| +17% | +$12.4M | 1.66% | 27 |
|
|
2013
Q2 | $57.7M | Buy |
+625,000
| New | +$57.7M | 1.29% | 32 |
|